TY - JOUR AU - Tarazan, Nehal AU - Alshehri, Moayad AU - Sharif, Sameer AU - Al Duhailib, Zainab AU - Møller, Morten Hylander AU - Belley-Cote, Emilie AU - Alshahrani, Mohammed AU - Centofanti, John AU - McIntyre, Lauralyn AU - Baw, Bandar AU - Meade, Maureen AU - Alhazzani, Waleed AU - for the GUIDE Group PY - 2020 DA - 2020/10/23 TI - Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials JO - Intensive Care Medicine Experimental SP - 61 VL - 8 IS - 1 AB - Existing clinical practice guidelines support the use of neuromuscular blocking agents (NMBA) in acute respiratory distress syndrome (ARDS); however, a recent large randomized clinical trial (RCT) has questioned this practice. Therefore, we updated a previous systematic review to determine the efficacy and safety of NMBAs in ARDS. SN - 2197-425X UR - https://doi.org/10.1186/s40635-020-00348-6 DO - 10.1186/s40635-020-00348-6 ID - Tarazan2020 ER -